Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study

por Anasagasti-Angulo, Lorenzo, Garcia-Vega, Yanelda, Barcelona-Perez, Silvia, Lopez-Saura, Pedro, Bello-Rivero, Iraldo
Publicado 2009

Construction, purification, and characterization of a chimeric TH1 antagonist

por Bello-Rivero, Iraldo, Torrez-Ruiz, Yeny, Blanco-Garcés, Elizabeth, Pentón-Rol, Giselle, Fernández-Batista, Osmani, Javier-González, Luís, Gerónimo-Perez, Haydee, López-Saura, Pedro
Publicado 2006

Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers

por Yera-Alos, Isis B, Alonso-Carbonell, Liuba, Valenzuela-Silva, Carmen M, Tuero-Iglesias, Angela D, Moreira-Martínez, Martha, Marrero-Rodríguez, Ivonne, López-Mola, Ernesto, López-Saura, Pedro A
Publicado 2013

Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study

por Suárez-Méndez, Roberto, García-García, Idrian, Fernández-Olivera, Norma, Valdés-Quintana, Magalys, Milanés-Virelles, María T, Carbonell, Dalia, Machado-Molina, Delfina, Valenzuela-Silva, Carmen M, López-Saura, Pedro A
Publicado 2004

Granulation Response and Partial Wound Closure Predict Healing in Clinical Trials on Advanced Diabetes Foot Ulcers Treated With Recombinant Human Epidermal Growth Factor

por Valenzuela-Silva, Carmen M., Tuero-Iglesias, Ángela D., García-Iglesias, Elizeth, González-Díaz, Odalys, del Río-Martín, Amaurys, Yera Alos, Isis Belkis, Fernández-Montequín, José I., López-Saura, Pedro A.
Publicado 2013

Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction

por Betancourt, Blas Y, Marrero-Miragaya, María A, Jiménez-López, Giset, Valenzuela-Silva, Carmen, García-Iglesias, Elizeth, Hernández-Bernal, Francisco, Debesa-García, Francisco, González-López, Tania, Alvarez-Falcón, Leovaldo, López-Saura, Pedro A
Publicado 2005

TNF-α and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica

por Pentón-Rol, Giselle, Cervantes-Llanos, Majel, Martínez-Sánchez, Gregorio, Cabrera-Gómez, José A, Valenzuela-Silva, Carmen M, Ramírez-Nuñez, Omar, Casanova-Orta, Mayté, Robinson-Agramonte, María A, Lopategui-Cabezas, Ileana, López-Saura, Pedro A
Publicado 2009

Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

por Solares, Ana M, Santana, Agueda, Baladrón, Idania, Valenzuela, Carmen, González, Carlos A, Díaz, Alina, Castillo, Dagnelia, Ramos, Thelvia, Gómez, Roberto, Alonso, Daniel F, Herrera, Luis, Sigman, Hugo, Perea, Silvio E, Acevedo, Boris E, López-Saura, Pedro
Publicado 2009

Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial

por Solares, Ana M., Baladron, Idania, Ramos, Thelvia, Valenzuela, Carmen, Borbon, Zaida, Fanjull, Sonia, Gonzalez, Leonardo, Castillo, Dagnelia, Esmir, Julio, Granadillo, Milaid, Batte, Aileen, Cintado, Alberto, Ale, Mayte, Fernandez de Cossio, Maria E., Ferrer, Annia, Torrens, Isis, Lopez-Saura, Pedro
Publicado 2011

Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: A parallel, randomized, double blind study

por Pérez-Oliva, Jorge F, Casanova-González, Martha, García-García, Idrian, Porrero-Martín, Pedro J, Valenzuela-Silva, Carmen M, Hernández-Montero, Tairí, Lagarde-Ampudia, Marcia, Casanova-Kutsareva, Yuri, Ávila-Albuerne, Yisel, Vargas-Batista, Alicia, Bobillo-López, Hailen, Herrera-Valdés, Raúl, López-Saura, Pedro A
Publicado 2005

Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study

por García-García, Idrian, González-Delgado, Carlos A, Valenzuela-Silva, Carmen M, Díaz-Machado, Alina, Cruz-Díaz, Marisol, Nodarse-Cuní, Hugo, Pérez-Pérez, Orlando, Bermúdez-Badell, Cimara H, Ferrero-Bibilonia, Joel, Páez-Meireles, Rolando, Bello-Rivero, Iraldo, Castro-Odio, Fidel R, López-Saura, Pedro A
Publicado 2010

Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers

por García-García, Idrian, Hernández-González, Ignacio, Díaz-Machado, Alina, González-Delgado, Carlos A., Pérez-Rodríguez, Sonia, García-Vega, Yanelda, Campos-Mojena, Rosario, Tuero-Iglesias, Ángela D., Valenzuela-Silva, Carmen M., Cruz-Ramírez, Alieski, Martín-Trujillo, Alis, Santana-Milián, Héctor, López-Saura, Pedro A., Bello-Rivero, Iraldo
Publicado 2016

Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study

por Milanés-Virelles, María T, García-García, Idrian, Santos-Herrera, Yamilet, Valdés-Quintana, Magalys, Valenzuela-Silva, Carmen M, Jiménez-Madrigal, Gaspar, Ramos-Gómez, Thelvia I, Bello-Rivero, Iraldo, Fernández-Olivera, Norma, Sánchez-de la Osa, Reinaldo B, Rodríguez-Acosta, Carmen, González-Méndez, Lidia, Martínez-Sánchez, Gregorio, López-Saura, Pedro A
Publicado 2008